Long Term Triple Non-Steroidal (CNI plus imTOR plus MMF) Maintenance Therapy in a Cohort of Kidney Transplanted Children

被引：0
|
作者：
Vilalta, R. [1 ]
Lara, E. [1 ]
Madrid, A. [1 ]
Munoz, M. [1 ]
Chocron, S. [1 ]
Ariceta, G. [1 ]
机构：
[1] Hosp Valle De Hebron, Barcelona, Spain
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-00701
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
A479
引用
收藏
页码：236 / 236
页数：1
相关论文
共 50 条
  • [21] SUCCESSFUL LONG-TERM TMA- AND REJECTION-FREE SURVIVAL OF A KIDNEY XENOGRAFT WITH TRIPLE XENOANTIGEN KNOCKOUT PLUS INSERTION OF MULTIPLE HUMAN TRANSGENES
    Ma, David
    Hirose, Takayuki
    Rosales, Ivy
    Sasaki, Hajime
    Colvin, Robert
    Markmann, Jim
    Qin, Wenning
    Kan, Yinan
    Layer, Jacob
    Youd, Michele
    Westlin, William
    Yang, Luhan
    Kawai, Tatsuo
    TRANSPLANTATION, 2020, 104 (09) : S82 - S82
  • [22] Successful Long-Term TMA- and Rejection-Free Survival of a Kidney Xenograft With Triple Xenoantigen Knockout Plus Insertion of Multiple Human Transgenes
    Hirose, T.
    Ma, D.
    Lassiter, G.
    Sasaki, H.
    Rosales, I.
    Coe, T.
    Rickert, C.
    Matheson, R.
    Colvin, R.
    Qin, W.
    Kan, Y.
    Layer, J.
    Stiede, K.
    Hall, K.
    Youd, M.
    Westlin, W.
    Curtis, M.
    Markmann, J. F.
    Kawai, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 477 - 477
  • [23] Successful Long-Term TMA- and Rejection- Free Survival of a Kidney Xenograft with Triple Xenoantigen Knockout Plus Insertion of Multiple Human Transgenes
    Ma, D. H.
    Sasaki, H.
    Hirose, T.
    Rosales, I.
    Dehnadi, A.
    Colvin, R.
    Markmann, J. F.
    Win, W.
    Kan, Y.
    Layer, J.
    Youd, M.
    Westlin, W.
    Yang, L.
    Kawai, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 752 - 753
  • [24] Fludarabine plus prednisone ± α-interferon followed or not by α-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia:: long term results of a randomized study
    Mauro, FR
    Zinzani, P
    Zaja, F
    Gentile, M
    Vegna, ML
    Stefoni, V
    Marin, L
    Fanin, R
    Baccarani, M
    Tura, S
    Mandelli, F
    HAEMATOLOGICA, 2003, 88 (12) : 1348 - 1357
  • [25] Helicobacter pylori eradication prior to initiation of long-term non-steroidal anti-inflammatory drug therapy in Chinese patients - a cost-effectiveness analysis
    You, JHS
    Lau, W
    Lee, IYC
    Yung, M
    Ching, JYL
    Chan, FKL
    Lee, KKC
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2006, 44 (04) : 149 - 153
  • [26] Alemtuzumab and Minimization Immunotherapy in Kidney Transplantation: Long-Term Results of Comparison With Rabbit Anti-Thymocyte Globulin and Standard Triple Maintenance Therapy
    Zachariah, M.
    Nader, N. D.
    Brar, J.
    Singh, N.
    Venuto, R.
    Patel, S.
    Said, M.
    Laftavi, M. R.
    Pankewycz, O.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (01) : 94 - 100
  • [27] High dose, long-term daily interferon plus ribavirin combination therapy for HCV (genotype 1 and non genotype 1)non responders.
    Lurie, Y
    Beer-Gabel, M
    Malnick, SDH
    Keter, D
    Rimon, E
    Mosenkis, B
    Stalgis, C
    Brass, DD
    HEPATOLOGY, 1999, 30 (04) : 620A - 620A
  • [28] Association of long-term use of non-steroidal anti-inflammatory drugs with knee osteoarthritis: a prospective multi-cohort study over 4-to-5 years
    Salis, Zubeyir
    Sainsbury, Amanda
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [29] Long-term clinical effects of aspirin-desensitization therapy among patients with poorly controlled asthma and non-steroidal anti-inflammatory drug hypersensitivity: An exploratory study
    Foerster-Ruhrmann, U.
    Zappe, S. -M.
    Szczepek, A. J.
    Olze, H.
    Rabe, U.
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2015, 21 (06) : 314 - 320
  • [30] Long-term follow-up of rituximab plus first-line mitoxantrone, chlorambucil, prednisolone and interferon-alpha as maintenance therapy in follicular lymphoma
    Michael Herold
    Christian W. Scholz
    Frank Rothmann
    Carsten Hirt
    Volker Lakner
    Ralph Naumann
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 1689 - 1695
12345